This study investigates the safety and tolerability of an investigational medication in patients with different types of cancer.
The study evaluates how well patients tolerate the investigational medication and checks for any side effects.
- Who can participate: Adults aged 18 and older with specific types of cancer may be eligible. Participants must have adequate organ function and a life expectancy of at least 90 days.
- Study details: Participants will receive the investigational medication to assess its safety. In some cases, a placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine, may be used for comparison.